Literature DB >> 27917617

Chronic oedema: a prevalent health care problem for UK health services.

Christine J Moffatt1, Vaughan Keeley2,3, Peter J Franks4,5, Anna Rich2, Lorraine L Pinnington3.   

Abstract

Chronic oedema (CO) is a major clinical problem worldwide, which has many important secondary consequences for health, activity and participation. Effective treatment planning and organisation of services is dependent on an understanding of the condition and its epidemiology. This cross-sectional study was designed to estimate the point prevalence of CO within the health services of one UK urban population and to determine the proportions that have concurrent leg ulceration. Patients with CO in all anatomic sites were ascertained by health care professionals in one acute and one community hospital, all relevant outpatient and community nursing services, general practices and all nursing/residential homes in one urban catchment area (Derby City). The presence and distribution of oedema was confirmed through a brief clinical examination. A battery of demographic and clinical details was recorded for each case. Within the study population of Derby City residents, 971 patients were identified with CO [estimated crude prevalence 3·93 per 1000, 95% confidence interval (CI) 3·69-4·19]. The prevalence was the highest among those aged 85 or above (28·75 per 1000) and was higher among women (5·37 per 1000) than men (2·48 per 1000). The prevalence among hospital inpatients was 28·5%. Only five (3%) patients in the community population had oedema related to cancer or cancer treatment. Of the 304 patients identified with oedema from the Derby hospitals or community health services, 121 (40%) had a concurrent leg ulcer. Prevalence statistics and current demographic trends indicate that CO is a major and growing health care problem.
© 2016 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Chronic oedema; Epidemiology; Health services; Lymphoedema; Prevalence

Mesh:

Year:  2016        PMID: 27917617      PMCID: PMC7950047          DOI: 10.1111/iwj.12694

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  8 in total

Review 1.  Lymphoedema: estimating the size of the problem.

Authors:  Anne F Williams; Peter J Franks; Christine J Moffatt
Journal:  Palliat Med       Date:  2005-06       Impact factor: 4.762

Review 2.  Health-related quality of life with lymphoedema: a review of the literature.

Authors:  Philip A Morgan; Peter J Franks; Christine J Moffatt
Journal:  Int Wound J       Date:  2005-03       Impact factor: 3.315

3.  The frequency of lymphedema in an adult spina bifida population.

Authors:  Angela M Garcia; Brad E Dicianno
Journal:  Am J Phys Med Rehabil       Date:  2011-02       Impact factor: 2.159

Review 4.  Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.

Authors:  Tracey DiSipio; Sheree Rye; Beth Newman; Sandi Hayes
Journal:  Lancet Oncol       Date:  2013-03-27       Impact factor: 41.316

5.  Prevalence of secondary lymphedema in patients with head and neck cancer.

Authors:  Jie Deng; Sheila H Ridner; Mary S Dietrich; Nancy Wells; Kenneth A Wallston; Robert J Sinard; Anthony J Cmelak; Barbara A Murphy
Journal:  J Pain Symptom Manage       Date:  2011-07-30       Impact factor: 3.612

6.  Prevalence of oedema of the lower limbs in multiple sclerosis patients: a vascular and lymphoscintigraphic study.

Authors:  C Solaro; M Messmer Uccelli; G Brichetto; G Augello; G Taddei; F Boccardo; F Buffoni; C Campisi; L Lopes; M A Battaglia; G L Mancardi
Journal:  Mult Scler       Date:  2006-10       Impact factor: 6.312

7.  Lymphoedema: an underestimated health problem.

Authors:  C J Moffatt; P J Franks; D C Doherty; A F Williams; C Badger; E Jeffs; N Bosanquet; P S Mortimer
Journal:  QJM       Date:  2003-10

Review 8.  Estimating the population burden of lymphedema.

Authors:  Stanley G Rockson; Kahealani K Rivera
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

  8 in total
  13 in total

1.  VIPAR, a quantitative approach to 3D histopathology applied to lymphatic malformations.

Authors:  René Hägerling; Dominik Drees; Aaron Scherzinger; Cathrin Dierkes; Silvia Martin-Almedina; Stefan Butz; Kristiana Gordon; Michael Schäfers; Klaus Hinrichs; Pia Ostergaard; Dietmar Vestweber; Tobias Goerge; Sahar Mansour; Xiaoyi Jiang; Peter S Mortimer; Friedemann Kiefer
Journal:  JCI Insight       Date:  2017-08-17

2.  Lymphedema Research Prioritization Partnership: A Collaborative Approach to Setting Research Priorities for Lymphedema Management.

Authors:  Emma Underwood; Mary Woods; Katie Riches; Vaughan Keeley; Anita Wallace; Jennifer Freeman
Journal:  Lymphat Res Biol       Date:  2018-10-24       Impact factor: 2.589

3.  The Prevalence and Functional Impact of Chronic Edema and Lymphedema in Japan: LIMPRINT Study.

Authors:  Misako Dai; Gojiro Nakagami; Junko Sugama; Noriko Kobayashi; Emiko Kimura; Yoko Arai; Aya Sato; Gregoire Mercier; Christine Moffatt; Susie Murray; Hiromi Sanada
Journal:  Lymphat Res Biol       Date:  2019-04       Impact factor: 2.589

4.  LIMPRINT: Prevalence of Chronic Edema in Health Services in Copenhagen, Denmark.

Authors:  Susan Nørregaard; Susan Bermark; Tonny Karlsmark; Peter J Franks; Susie Murray; Christine J Moffatt
Journal:  Lymphat Res Biol       Date:  2019-04       Impact factor: 2.589

5.  LIMPRINT: A Sociological Perspective on "Chronic Edema".

Authors:  Stuart Nairn; Eleanor Dring; Aimee Aubeeluck; Isabelle Quere; Christine Moffatt
Journal:  Lymphat Res Biol       Date:  2019-04       Impact factor: 2.589

6.  Prevalence and Risk Factors for Chronic Edema in U.K. Community Nursing Services.

Authors:  Christine J Moffatt; Rebecca Gaskin; Martina Sykorova; Eleanor Dring; Aimee Aubeeluck; Peter J Franks; Paul Windrum; Gregoire Mercier; Lorraine Pinnington; Isabelle Quere
Journal:  Lymphat Res Biol       Date:  2019-04       Impact factor: 2.589

Review 7.  The Concept of Chronic Edema-A Neglected Public Health Issue and an International Response: The LIMPRINT Study.

Authors:  Christine Moffatt; Vaughan Keeley; Isabelle Quere
Journal:  Lymphat Res Biol       Date:  2019-04       Impact factor: 2.589

8.  LIMPRINT: Estimation of the Prevalence of Lymphoedema/Chronic Oedema in Acute Hospital in In-Patients.

Authors:  Isabelle Quéré; Sylvie Palmier; Susan Noerregaard; Jenica Pastor; Martina Sykorova; Eleanor Dring; Peter J Franks; Susie Murray; Vaughan Keeley; Susan Bermark; Tonny Karlsmark; Norah Kyne; Mary-Paula Colgan; Marie-Michelle Coulombe; Sandrine Mestre; Gregoire Mercier; Christine J Moffatt
Journal:  Lymphat Res Biol       Date:  2019-04       Impact factor: 2.589

9.  LIMPRINT: The UK Experience-Subjective Control of Swelling in Patients Attending Specialist Lymphedema Services.

Authors:  Christine J Moffatt; Vaughan Keeley; Andrew Hughes; Kath Clark; Jill Lisle; Margaret Benson; Rebecca Gaskin; Martina Sykorova; Eleanor Dring; Susie Murray; Gregoire Mercier; Isabelle Quere; Peter J Franks
Journal:  Lymphat Res Biol       Date:  2019-04       Impact factor: 2.589

10.  Clinical and Ethical Challenges in Undertaking LIMPRINT in Vulnerable Populations.

Authors:  Christine J Moffatt; Martina Sykorova; Aimee Aubeeluck; Peter John Franks; Sarah Pankhurst; Rachel Bussey; Siobhan Whiston; Susie Murray; Gregoire Mercier; Isabelle Quere; Susan Gordon
Journal:  Lymphat Res Biol       Date:  2019-04       Impact factor: 2.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.